Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.
The global Computational Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Computational Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Drug Discovery.
Report Scope
The Computational Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMRI
Charles River
厂肠丑谤枚诲颈苍驳别谤
Evotec
Bayers
GVK Biosciences
AstraZeneca
BioDuro
BOC Sciences
Aris Pharmaceuticals
ChemDiv
RTI International
XRQTC
Pharmaron
Segment by Type
Structure-based Drug Design (SBDD)
Ligand-based Drug Design (LBDD)
Sequence-based Approaches
Segment by Application
Oncological Disorders
Neurological Disorders
Immunological Disorders
Infectious Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Drug Discovery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Structure-based Drug Design (SBDD)
1.2.3 Ligand-based Drug Design (LBDD)
1.2.4 Sequence-based Approaches
1.3 Market by Application
1.3.1 Global Computational Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Immunological Disorders
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Drug Discovery Market Perspective (2019-2030)
2.2 Computational Drug Discovery Growth Trends by Region
2.2.1 Global Computational Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computational Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Computational Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Computational Drug Discovery Market Dynamics
2.3.1 Computational Drug Discovery Industry Trends
2.3.2 Computational Drug Discovery Market Drivers
2.3.3 Computational Drug Discovery Market Challenges
2.3.4 Computational Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Drug Discovery Players by Revenue
3.1.1 Global Top Computational Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Drug Discovery Revenue
3.4 Global Computational Drug Discovery Market Concentration Ratio
3.4.1 Global Computational Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Drug Discovery Revenue in 2023
3.5 Computational Drug Discovery Key Players Head office and Area Served
3.6 Key Players Computational Drug Discovery Product Solution and Service
3.7 Date of Enter into Computational Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Drug Discovery Breakdown Data by Type
4.1 Global Computational Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Computational Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Computational Drug Discovery Breakdown Data by Application
5.1 Global Computational Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Computational Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computational Drug Discovery Market Size (2019-2030)
6.2 North America Computational Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computational Drug Discovery Market Size by Country (2019-2024)
6.4 North America Computational Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Drug Discovery Market Size (2019-2030)
7.2 Europe Computational Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computational Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Computational Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Computational Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computational Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Computational Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Drug Discovery Market Size (2019-2030)
9.2 Latin America Computational Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computational Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Computational Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Computational Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computational Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Computational Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMRI
11.1.1 AMRI Company Detail
11.1.2 AMRI Business Overview
11.1.3 AMRI Computational Drug Discovery Introduction
11.1.4 AMRI Revenue in Computational Drug Discovery Business (2019-2024)
11.1.5 AMRI Recent Development
11.2 Charles River
11.2.1 Charles River Company Detail
11.2.2 Charles River Business Overview
11.2.3 Charles River Computational Drug Discovery Introduction
11.2.4 Charles River Revenue in Computational Drug Discovery Business (2019-2024)
11.2.5 Charles River Recent Development
11.3 厂肠丑谤枚诲颈苍驳别谤
11.3.1 厂肠丑谤枚诲颈苍驳别谤 Company Detail
11.3.2 厂肠丑谤枚诲颈苍驳别谤 Business Overview
11.3.3 厂肠丑谤枚诲颈苍驳别谤 Computational Drug Discovery Introduction
11.3.4 厂肠丑谤枚诲颈苍驳别谤 Revenue in Computational Drug Discovery Business (2019-2024)
11.3.5 厂肠丑谤枚诲颈苍驳别谤 Recent Development
11.4 Evotec
11.4.1 Evotec Company Detail
11.4.2 Evotec Business Overview
11.4.3 Evotec Computational Drug Discovery Introduction
11.4.4 Evotec Revenue in Computational Drug Discovery Business (2019-2024)
11.4.5 Evotec Recent Development
11.5 Bayers
11.5.1 Bayers Company Detail
11.5.2 Bayers Business Overview
11.5.3 Bayers Computational Drug Discovery Introduction
11.5.4 Bayers Revenue in Computational Drug Discovery Business (2019-2024)
11.5.5 Bayers Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Detail
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Computational Drug Discovery Introduction
11.6.4 GVK Biosciences Revenue in Computational Drug Discovery Business (2019-2024)
11.6.5 GVK Biosciences Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Computational Drug Discovery Introduction
11.7.4 AstraZeneca Revenue in Computational Drug Discovery Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 BioDuro
11.8.1 BioDuro Company Detail
11.8.2 BioDuro Business Overview
11.8.3 BioDuro Computational Drug Discovery Introduction
11.8.4 BioDuro Revenue in Computational Drug Discovery Business (2019-2024)
11.8.5 BioDuro Recent Development
11.9 BOC Sciences
11.9.1 BOC Sciences Company Detail
11.9.2 BOC Sciences Business Overview
11.9.3 BOC Sciences Computational Drug Discovery Introduction
11.9.4 BOC Sciences Revenue in Computational Drug Discovery Business (2019-2024)
11.9.5 BOC Sciences Recent Development
11.10 Aris Pharmaceuticals
11.10.1 Aris Pharmaceuticals Company Detail
11.10.2 Aris Pharmaceuticals Business Overview
11.10.3 Aris Pharmaceuticals Computational Drug Discovery Introduction
11.10.4 Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2019-2024)
11.10.5 Aris Pharmaceuticals Recent Development
11.11 ChemDiv
11.11.1 ChemDiv Company Detail
11.11.2 ChemDiv Business Overview
11.11.3 ChemDiv Computational Drug Discovery Introduction
11.11.4 ChemDiv Revenue in Computational Drug Discovery Business (2019-2024)
11.11.5 ChemDiv Recent Development
11.12 RTI International
11.12.1 RTI International Company Detail
11.12.2 RTI International Business Overview
11.12.3 RTI International Computational Drug Discovery Introduction
11.12.4 RTI International Revenue in Computational Drug Discovery Business (2019-2024)
11.12.5 RTI International Recent Development
11.13 XRQTC
11.13.1 XRQTC Company Detail
11.13.2 XRQTC Business Overview
11.13.3 XRQTC Computational Drug Discovery Introduction
11.13.4 XRQTC Revenue in Computational Drug Discovery Business (2019-2024)
11.13.5 XRQTC Recent Development
11.14 Pharmaron
11.14.1 Pharmaron Company Detail
11.14.2 Pharmaron Business Overview
11.14.3 Pharmaron Computational Drug Discovery Introduction
11.14.4 Pharmaron Revenue in Computational Drug Discovery Business (2019-2024)
11.14.5 Pharmaron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
AMRI
Charles River
厂肠丑谤枚诲颈苍驳别谤
Evotec
Bayers
GVK Biosciences
AstraZeneca
BioDuro
BOC Sciences
Aris Pharmaceuticals
ChemDiv
RTI International
XRQTC
Pharmaron
听
听
*If Applicable.
